ketoconazole has been researched along with Actinomycetoma in 54 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"A one year study of the efficacy of the antifungal agent ketoconazole in non-invasive pulmonary aspergillosis was carried out." | 9.06 | Trial of ketoconazole in non-invasive pulmonary aspergillosis. ( Faux, JA; Lane, DJ; Shale, DJ, 1987) |
"The authors present the use of ketoconazole in 27 cases of paracoccidioidomycosis, eight of mycetoma, seven of chromomycosis, four of systemic candidiasis and one of lobomycosis." | 9.05 | Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole. ( Cucé, LC; Sampaio, SA; Wroclawski, EL, 1980) |
"Currently, therapy of black-grain mycetoma caused by Madurella mycetomatis consists of extensive debridement of the infected tissue combined with prolonged antifungal therapy with ketoconazole or itraconazole." | 7.78 | In vitro antifungal activity of isavuconazole against Madurella mycetomatis. ( Curfs-Breuker, I; Fahal, AH; Kloezen, W; Meis, JF; van de Sande, WW, 2012) |
"Ten patients with eumycetoma were treated with oral ketoconazole in the dosage of 400mg/day for 8 to 24 months." | 7.68 | Treatment of eumycetoma with ketoconazole. ( Venugopal, PV; Venugopal, TV, 1993) |
"We report the case of a 30-year-old Nigerian patient with mycetoma of the foot without bone involvement caused by Fusarium sp." | 7.68 | Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole. ( Baudraz-Rosselet, F; Boccard, C; Borradori, L; Frenk, E; Ginalsky, JM; Monod, M; Vion, B, 1992) |
"Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 7.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
"Eumycetoma is a chronic progressive disabling and destructive inflammatory disease which is commonly caused by the fungus Madurella mycetomatis." | 6.79 | The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection. ( Fahal, AH; Mahgoub, el S; Mhmoud, NA; van de Sande, WW, 2014) |
"One of the hallmarks of eumycetoma is the formation of fungal grains, which are secreted by multiple sinuses in infected tissues." | 5.34 | Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. ( Ahmed, AO; Coppens, J; de Kat, J; Fahal, A; van Belkum, A; van de Sande, WW; Verbrugh, H, 2007) |
"A case of mycetoma of the lower leg (Madura foot) with bone involvement caused by Petriellidium boydii is presented." | 5.27 | [Mycetoma caused by Petriellidium boydii: treatment with ketoconazole]. ( Auböck, J; Fritsch, P; Pichler, E, 1985) |
"Griseofulvin has been used to improve the clinical appearances in eumycetoma (fungal mycetoma) cases which respond poorly to antifungal chemotherapy and it is suggested that its effect in this condition depends, in part, on its ability to inhibit leucocyte aggregation around mycetoma grains." | 5.27 | Leucocyte chemotaxis to mycetoma agents--the effect of the antifungal drugs griseofulvin and ketoconazole. ( Hay, RJ; Yousif, MA, 1987) |
"A one year study of the efficacy of the antifungal agent ketoconazole in non-invasive pulmonary aspergillosis was carried out." | 5.06 | Trial of ketoconazole in non-invasive pulmonary aspergillosis. ( Faux, JA; Lane, DJ; Shale, DJ, 1987) |
"The authors present the use of ketoconazole in 27 cases of paracoccidioidomycosis, eight of mycetoma, seven of chromomycosis, four of systemic candidiasis and one of lobomycosis." | 5.05 | Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole. ( Cucé, LC; Sampaio, SA; Wroclawski, EL, 1980) |
"Currently, therapy of black-grain mycetoma caused by Madurella mycetomatis consists of extensive debridement of the infected tissue combined with prolonged antifungal therapy with ketoconazole or itraconazole." | 3.78 | In vitro antifungal activity of isavuconazole against Madurella mycetomatis. ( Curfs-Breuker, I; Fahal, AH; Kloezen, W; Meis, JF; van de Sande, WW, 2012) |
"Eumycetoma caused by Madurella mycetomatis is treated surgically and with high doses of ketoconazole." | 3.76 | Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents. ( Bakker-Woudenberg, IA; Fahal, AH; van Belkum, A; van de Sande, WW, 2010) |
"We report the case of a 30-year-old Nigerian patient with mycetoma of the foot without bone involvement caused by Fusarium sp." | 3.68 | Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole. ( Baudraz-Rosselet, F; Boccard, C; Borradori, L; Frenk, E; Ginalsky, JM; Monod, M; Vion, B, 1992) |
"Ten patients with eumycetoma were treated with oral ketoconazole in the dosage of 400mg/day for 8 to 24 months." | 3.68 | Treatment of eumycetoma with ketoconazole. ( Venugopal, PV; Venugopal, TV, 1993) |
"Forty-eight cases of deep mycoses were studied and treated with ketoconazole, each with in vitro evaluation of the minimum inhibitory concentrations (MIC) of the causative fungi, in vivo pharmacokinetic, clinical, and mycologic evaluations, several months to two years after the treatment was stopped." | 3.66 | Laboratory and clinical assessment of ketoconazole in deep-seated mycoses. ( Drouhet, E; Dupont, B, 1983) |
"Eumycetoma is a chronic progressive disabling and destructive inflammatory disease which is commonly caused by the fungus Madurella mycetomatis." | 2.79 | The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection. ( Fahal, AH; Mahgoub, el S; Mhmoud, NA; van de Sande, WW, 2014) |
"Mycetoma is a chronic granulomatous infection that is present worldwide and endemic in tropical and subtropical regions." | 2.43 | Mycetoma : a review. ( Khachemoune, A; Lichon, V, 2006) |
" Ketoconazole at a dosage of 400 mg/day is the medical treatment of choice for eumycetoma caused by M." | 2.39 | Treatment of eumycetoma and actinomycetoma. ( Rodríguez, MA; Salinas, MC; Welsh, O, 1995) |
"The previous cases of Pseudallescheria brain abscess are reviewed, and the histopathologic features of Pseudallescheria which permit its differentiation from Aspergillus and other fungi are discussed." | 2.38 | Cerebral Pseudallescheria boydii infection: unique occurrence of fungus ball formation in the brain. ( Amenta, PS; Finkelstein, SD; Schwartz, DA, 1989) |
"flavus eumycetoma confirmed by isolation, molecular identification and immunohistochemical analysis." | 1.42 | Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry. ( Abbas, MA; Ahmed, SA; Al-Hatmi, AM; de Hoog, GS; Jouvion, G; Kolecka, A; Mahgoub, el S, 2015) |
"Mycetomas are endemic to northwest Africa." | 1.39 | [Orbital mycetoma: a case report]. ( Agboton, G; Diakhaté, M; Dieng, M; Dieng, MT; Diop, Y; Gueye, NN; Ndiaye Sow, MN; Seck, SM, 2013) |
"In the eumycetoma group, longer treatment duration (OR=1." | 1.38 | Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan. ( Abdel-Rahman, ME; El Hassan, TA; Fahal, AH; Mahgoub, el S; Zein, HA, 2012) |
"Madurella mycetomatis is the main causative organism of human eumycetoma in Sudan." | 1.35 | Abdominal wall mycetoma presented as obstructed incisional hernia of cesarean section in eastern Sudan. ( Adam, ES; Adam, I; Elhardello, OA, 2009) |
"One of the hallmarks of eumycetoma is the formation of fungal grains, which are secreted by multiple sinuses in infected tissues." | 1.34 | Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. ( Ahmed, AO; Coppens, J; de Kat, J; Fahal, A; van Belkum, A; van de Sande, WW; Verbrugh, H, 2007) |
"A case of eumycetoma of foot in an 8-year old male child was clinically diagnosed as chronic osteomyelitis and was microbiologically confirmed as eumycetoma." | 1.34 | Eumycetoma pedis due to Exophiala jeanselmei. ( Aggarwal, P; Capoor, MR; Deb, M; Hasan, A; Khanna, G; Nair, D, 2007) |
"The pre-operative diagnosis of eumycetoma in this location is extremely difficult and the role of histopathology is very important to characterize this uncommon lesion." | 1.34 | Eumycetoma presenting as a cerebellopontine angle mass lesion. ( Garg, A; Kasliwal, MK; Mridha, AR; Sai Kiran, NA; Sharma, BS; Sharma, MC; Suri, A; Suri, V, 2007) |
" They developed serious deformities of the lower extremity despite long-term use of antimycotic and antibiotic medication." | 1.30 | The Madura foot: an "innocent foot mycosis"? ( Ten Broeke, R; Walenkamp, G, 1998) |
"Although blastomycosis is endemic in North America, only 4 cases have been identified in Natal during the last 25 years, and all presented with atypical clinical features." | 1.28 | Tropical mycoses. ( Bayles, MA, 1992) |
"Maduromycosis is a chronic granulomatous condition caused by fungal infection and is rarely encountered in Europe." | 1.28 | Madura foot of the chest wall; cure after radical excision. ( Donnelly, RJ; McCormick, CS; Shafei, H, 1992) |
"The results in histoplasmosis are encouraging as are the results in chromomycosis particularly those cases associated with C." | 1.28 | [Tropical mycoses]. ( Bayles, MA, 1991) |
"Mycetoma is a variety of deep mycoses." | 1.28 | [Mycetoma]. ( Bilusiak, DM; Sviridiuk, VZ, 1990) |
"Griseofulvin has been used to improve the clinical appearances in eumycetoma (fungal mycetoma) cases which respond poorly to antifungal chemotherapy and it is suggested that its effect in this condition depends, in part, on its ability to inhibit leucocyte aggregation around mycetoma grains." | 1.27 | Leucocyte chemotaxis to mycetoma agents--the effect of the antifungal drugs griseofulvin and ketoconazole. ( Hay, RJ; Yousif, MA, 1987) |
"Mycotic mycetoma is a chronic, granulomatous and fistulous tropical disease caused by hyphomycetes of different families." | 1.27 | [Mycotic mycetoma (eumycetoma) caused by Madurella mycetomi]. ( Bauer, R; Mittag, H; Montag, H; Niedecken, HW, 1985) |
"A case of mycetoma of the lower leg (Madura foot) with bone involvement caused by Petriellidium boydii is presented." | 1.27 | [Mycetoma caused by Petriellidium boydii: treatment with ketoconazole]. ( Auböck, J; Fritsch, P; Pichler, E, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (29.63) | 18.7374 |
1990's | 24 (44.44) | 18.2507 |
2000's | 7 (12.96) | 29.6817 |
2010's | 7 (12.96) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
van de Sande, WW | 4 |
Fahal, AH | 5 |
Bakker-Woudenberg, IA | 1 |
van Belkum, A | 2 |
Mhmoud, NA | 1 |
Mahgoub, el S | 3 |
Ahmed, SA | 1 |
Abbas, MA | 1 |
Jouvion, G | 1 |
Al-Hatmi, AM | 1 |
de Hoog, GS | 1 |
Kolecka, A | 1 |
Zein, HA | 1 |
El Hassan, TA | 1 |
Abdel-Rahman, ME | 1 |
Kloezen, W | 1 |
Meis, JF | 1 |
Curfs-Breuker, I | 1 |
Gueye, NN | 1 |
Seck, SM | 1 |
Diop, Y | 1 |
Ndiaye Sow, MN | 1 |
Agboton, G | 1 |
Diakhaté, M | 1 |
Dieng, M | 1 |
Dieng, MT | 1 |
Sultanov, GA | 1 |
Azimov, EKh | 1 |
Ibishov, KG | 1 |
Lichon, V | 1 |
Khachemoune, A | 1 |
Sai Kiran, NA | 1 |
Kasliwal, MK | 1 |
Suri, A | 1 |
Sharma, BS | 1 |
Suri, V | 1 |
Mridha, AR | 1 |
Sharma, MC | 1 |
Garg, A | 1 |
Elhardello, OA | 1 |
Adam, ES | 1 |
Adam, I | 1 |
Capoor, MR | 1 |
Khanna, G | 1 |
Nair, D | 1 |
Hasan, A | 1 |
Deb, M | 1 |
Aggarwal, P | 1 |
de Kat, J | 1 |
Coppens, J | 1 |
Ahmed, AO | 1 |
Fahal, A | 1 |
Verbrugh, H | 1 |
Galgiani, JN | 1 |
Stevens, DA | 1 |
Graybill, JR | 1 |
Stevens, DL | 2 |
Tillinghast, AJ | 1 |
Levine, HB | 1 |
Mahgoub, ES | 1 |
Gumaa, SA | 1 |
Simpson, A | 1 |
Singh, SR | 1 |
Cucé, LC | 1 |
Wroclawski, EL | 1 |
Sampaio, SA | 1 |
Drouhet, E | 1 |
Dupont, B | 1 |
Dellestable, F | 1 |
Kures, L | 1 |
Mainard, D | 1 |
Pere, P | 1 |
Gaucher, A | 1 |
Venugopal, PV | 1 |
Venugopal, TV | 1 |
Nomdedéu, J | 1 |
Brunet, S | 1 |
Martino, R | 1 |
Altés, A | 1 |
Ausina, V | 1 |
Domingo-Albós, A | 1 |
Goldberg, SL | 1 |
Geha, DJ | 1 |
Marshall, WF | 1 |
Inwards, DJ | 1 |
Hoagland, HC | 1 |
Buiting, AG | 1 |
Visser, LG | 1 |
Barge, RM | 1 |
van 't Wout, JW | 1 |
Hung, LH | 1 |
Norwood, LA | 1 |
Nozais, JP | 1 |
Canel, MA | 1 |
Datry, A | 1 |
Danis, M | 1 |
Welsh, O | 1 |
Salinas, MC | 1 |
Rodríguez, MA | 1 |
Carney, MD | 1 |
Tabassian, A | 1 |
Guerry, RK | 1 |
Ten Broeke, R | 1 |
Walenkamp, G | 1 |
Janaki, C | 1 |
Sentamilselvi, G | 1 |
Janaki, VR | 1 |
Devesh, S | 1 |
Ajithados, K | 1 |
Débat-Zoguéreh, D | 1 |
Badiaga, S | 1 |
Andrac-Meyer, L | 1 |
Delmont, J | 1 |
Brouqui, P | 1 |
Morino, G | 1 |
Giaccardi, GC | 1 |
Brundisini, R | 1 |
Ansaloni, L | 1 |
Giaccardi, S | 1 |
Burdon, JG | 1 |
Barnes, M | 2 |
Harris, A | 2 |
Bayles, MA | 2 |
Pether, JV | 1 |
Jones, W | 1 |
Greatorex, FB | 1 |
Bunting, W | 1 |
Shafei, H | 1 |
McCormick, CS | 1 |
Donnelly, RJ | 1 |
Baudraz-Rosselet, F | 1 |
Monod, M | 1 |
Borradori, L | 1 |
Ginalsky, JM | 1 |
Vion, B | 1 |
Boccard, C | 1 |
Frenk, E | 1 |
Alteras, I | 1 |
Hagler, J | 1 |
Trattner, A | 1 |
Morojinski, G | 1 |
Segal, R | 1 |
Sandbank, M | 1 |
Elad, D | 1 |
Orgad, U | 1 |
Yakobson, B | 1 |
Perl, S | 1 |
Golomb, P | 1 |
Trainin, R | 1 |
Tsur, I | 1 |
Shenkler, S | 1 |
Bor, A | 1 |
Burdon, J | 1 |
Lambrechts, N | 1 |
Collett, MG | 1 |
Henton, M | 1 |
Visvanathan, R | 1 |
Bilusiak, DM | 1 |
Sviridiuk, VZ | 1 |
Schwartz, DA | 1 |
Amenta, PS | 1 |
Finkelstein, SD | 1 |
Bourrel, P | 1 |
Andreu, JM | 2 |
Cazenave, JC | 1 |
Shale, DJ | 1 |
Faux, JA | 1 |
Lane, DJ | 1 |
Willsteed, E | 1 |
Regan, W | 1 |
Yousif, MA | 1 |
Hay, RJ | 2 |
Ansari, RA | 1 |
Hindson, DA | 1 |
Kloss, JG | 1 |
Heilesen, AM | 1 |
Rasmussen, E | 1 |
Mittag, H | 1 |
Niedecken, HW | 1 |
Montag, H | 1 |
Bauer, R | 1 |
Auböck, J | 1 |
Pichler, E | 1 |
Fritsch, P | 1 |
5 reviews available for ketoconazole and Actinomycetoma
Article | Year |
---|---|
Mycetoma : a review.
Topics: Actinomycetales Infections; Antifungal Agents; Diagnosis, Differential; Fungi; Humans; Itraconazole; | 2006 |
Fungal arthritis due to Pseudallescheria boydii (Scedosporium apiospermum).
Topics: Arthritis, Infectious; Humans; Ketoconazole; Knee Joint; Magnetic Resonance Imaging; Male; Microscop | 1994 |
Osteomyelitis due to Pseudallescheria boydii.
Topics: Administration, Oral; Adult; Amputation, Surgical; Arthritis, Infectious; Arthroscopy; Biopsy; Diagn | 1993 |
Treatment of eumycetoma and actinomycetoma.
Topics: Actinomycetales; Amphotericin B; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycetoma; No | 1995 |
Cerebral Pseudallescheria boydii infection: unique occurrence of fungus ball formation in the brain.
Topics: Adult; Brain Abscess; Humans; Ketoconazole; Male; Miconazole; Mycetoma; Pseudallescheria | 1989 |
3 trials available for ketoconazole and Actinomycetoma
Article | Year |
---|---|
The combination of amoxicillin-clavulanic acid and ketoconazole in the treatment of Madurella mycetomatis eumycetoma and Staphylococcus aureus co-infection.
Topics: Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antif | 2014 |
Treatment of paracoccidioidomycosis, candidiasis, chromomycosis, lobomycosis, and mycetoma with ketoconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Chromoblastomycosis; Clinical Trials as Top | 1980 |
Trial of ketoconazole in non-invasive pulmonary aspergillosis.
Topics: Adult; Aged; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Clinica | 1987 |
46 other studies available for ketoconazole and Actinomycetoma
Article | Year |
---|---|
Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents.
Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echin | 2010 |
Mycetoma: A global medical and socio-economic dilemma.
Topics: Antifungal Agents; Biomedical Research; Cost-Benefit Analysis; Global Health; Health Services Access | 2017 |
Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Chronic Disease; Delayed Diagnosis; Diagnostic | 2015 |
Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amputation, Surgical; Antifungal Agents; Child; Child, P | 2012 |
In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Madurella; Microbial Sensitivity Tests; Mycet | 2012 |
[Orbital mycetoma: a case report].
Topics: Adolescent; Antifungal Agents; Exophthalmos; Eye Enucleation; Eye Infections, Fungal; Humans; Ketoco | 2013 |
[Madura foot (mycetoma)].
Topics: Adult; Amphotericin B; Amputation, Surgical; Anti-Bacterial Agents; Anti-Infective Agents; Antifunga | 2003 |
Eumycetoma presenting as a cerebellopontine angle mass lesion.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Edema; Brain Stem; Cerebellar Diseases; Cerebellopon | 2007 |
Abdominal wall mycetoma presented as obstructed incisional hernia of cesarean section in eastern Sudan.
Topics: Abdominal Wall; Cesarean Section; Cicatrix; Diagnosis, Differential; Female; Hernia, Abdominal; Huma | 2009 |
Eumycetoma pedis due to Exophiala jeanselmei.
Topics: Antifungal Agents; Child; Exophiala; Foot Dermatoses; Histocytochemistry; Humans; Ketoconazole; Leg; | 2007 |
Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
Topics: Antifungal Agents; Drug Resistance, Multiple, Fungal; Humans; Itraconazole; Ketoconazole; Madurella; | 2007 |
Pseudallescheria boydii infections treated with ketoconazole. Clinical evaluations of seven patients and in vitro susceptibility results.
Topics: Aged; Combined Modality Therapy; Female; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Miconazo | 1984 |
Ketoconazole in the treatment of eumycetoma due to Madurella mycetomii.
Topics: Adult; Aged; Child; Female; Humans; Ketoconazole; Male; Middle Aged; Mitosporic Fungi; Mycetoma | 1984 |
A case of Madura foot.
Topics: Drug Therapy, Combination; Foot Dermatoses; Humans; Ketoconazole; Male; Miconazole; Middle Aged; Myc | 1984 |
Laboratory and clinical assessment of ketoconazole in deep-seated mycoses.
Topics: Adolescent; Adult; Antifungal Agents; Arthritis, Infectious; Blastomycosis; Candidiasis; Candidiasis | 1983 |
Treatment of eumycetoma with ketoconazole.
Topics: Acremonium; Adolescent; Adult; Female; Foot Dermatoses; Humans; Ketoconazole; Male; Middle Aged; Mit | 1993 |
Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report.
Topics: Adult; Antifungal Agents; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Male; Mycetoma | 1993 |
Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantat | 1993 |
[Mycetoma of the foot; a disease from the tropics].
Topics: Antifungal Agents; Cladosporium; Combined Modality Therapy; Debridement; Female; Foot Diseases; Fusa | 1993 |
[Mycetoma of the neck and the nape of the neck due to Madurella mycetomatis. Apropos of a case in Mauritania].
Topics: Adult; Antifungal Agents; Dermatomycoses; Humans; Itraconazole; Ketoconazole; Male; Mauritania; Mito | 1995 |
Pseudo-Allescheria boydii endophthalmitis.
Topics: Antifungal Agents; Child; Endophthalmitis; Eye Injuries; Humans; Ketoconazole; Male; Mycetoma; Pseud | 1996 |
The Madura foot: an "innocent foot mycosis"?
Topics: Adult; Aged; Amputation, Surgical; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; | 1998 |
Case report. Eumycetoma due to Curvularia lunata.
Topics: Administration, Oral; Adult; Antifungal Agents; Humans; Ketoconazole; Male; Mitosporic Fungi; Myceto | 1999 |
[Diagnostic case. Mycetoma].
Topics: Adult; Antifungal Agents; Dermatomycoses; Female; Foot Dermatoses; Humans; Ketoconazole; Mycetoma | 1999 |
A unique case of bladder mycetoma.
Topics: Adult; Cutaneous Fistula; Diagnosis, Differential; Humans; Ketoconazole; Madurella; Male; Mycetoma; | 2002 |
Treatment of pulmonary aspergilloma with itraconazole.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Mycetoma | 1992 |
Tropical mycoses.
Topics: Adult; Aged; Antifungal Agents; Blastomycosis; Chromoblastomycosis; Drug Therapy, Combination; Femal | 1992 |
Acute pyogenic Pseudallescheria boydii foot infection sequentially treated with miconazole and itraconazole.
Topics: Acute Disease; Antifungal Agents; Foot Diseases; Humans; Itraconazole; Ketoconazole; Male; Miconazol | 1992 |
Madura foot of the chest wall; cure after radical excision.
Topics: Adult; Humans; Ketoconazole; Male; Mitosporic Fungi; Mycetoma; Ribs | 1992 |
Mycetoma of the foot due to Fusarium sp. treated with oral ketoconazole.
Topics: Administration, Oral; Adult; Foot Dermatoses; Fusarium; Humans; Ketoconazole; Male; Mycetoma | 1992 |
[Mycetoma with black granules: first case in a native of Israel].
Topics: Adult; Biopsy; Cytoplasmic Granules; Dose-Response Relationship, Drug; Foot Dermatoses; Humans; Isra | 1992 |
[Tropical mycoses].
Topics: Antifungal Agents; Blastomycosis; Chromoblastomycosis; Clinical Trials as Topic; Female; Histoplasmo | 1991 |
Eumycetoma caused by Curvularia lunata in a dog.
Topics: Animals; Dog Diseases; Dogs; Granuloma; Itraconazole; Ketoconazole; Male; Microscopy, Electron, Scan | 1991 |
Itraconazole for pulmonary mycetoma.
Topics: Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Lung Di | 1991 |
Black grain eumycetoma (Madurella mycetomatis) in the abdominal cavity of a dog.
Topics: Abdomen; Animals; Culture Media; Dog Diseases; Dogs; Escherichia coli; Female; Fluconazole; Granulom | 1991 |
Madura foot: a surgical cure.
Topics: Clotrimazole; Humans; Ketoconazole; Mycetoma | 1991 |
[Mycetoma].
Topics: Adult; Amputation, Surgical; Female; Groin; Humans; Ketoconazole; Leg Dermatoses; Male; Mauritania; | 1990 |
[Mycetoma of the hand. Apropos of 10 cases].
Topics: Adolescent; Adult; Aged; Female; Hand Dermatoses; Humans; Ketoconazole; Male; Mycetoma; Preoperative | 1989 |
Treatment of Pseudallescheria boydii infection with oral ketoconazole and topical miconazole.
Topics: Administration, Oral; Administration, Topical; Aged; Humans; Ketoconazole; Male; Miconazole; Mycetom | 1987 |
Leucocyte chemotaxis to mycetoma agents--the effect of the antifungal drugs griseofulvin and ketoconazole.
Topics: Antigens, Fungal; Chemotaxis, Leukocyte; Griseofulvin; Humans; Ketoconazole; Mycetoma; Neutrophils | 1987 |
[Value of ketoconazole in combination with the surgical treatment of fungal mycetoma].
Topics: Combined Modality Therapy; Humans; Ketoconazole; Mycetoma | 1986 |
Pseudallescheria boydii arthritis and osteomyelitis in a patient with Cushing's disease.
Topics: Adrenalectomy; Arthritis, Infectious; Combined Modality Therapy; Cushing Syndrome; Humans; Ketoconaz | 1987 |
[Madura foot].
Topics: Female; Foot Dermatoses; Humans; Ketoconazole; Middle Aged; Mycetoma | 1987 |
Ketoconazole: a reappraisal.
Topics: Adult; Candidiasis; Chemical and Drug Induced Liver Injury; Dermatomycoses; Female; Humans; Ketocona | 1985 |
[Mycotic mycetoma (eumycetoma) caused by Madurella mycetomi].
Topics: Adult; Amoxicillin; Combined Modality Therapy; Foot Dermatoses; Humans; Ketoconazole; Male; Mitospor | 1985 |
[Mycetoma caused by Petriellidium boydii: treatment with ketoconazole].
Topics: Adult; Amputation, Surgical; Foot Dermatoses; Humans; Ketoconazole; Male; Mycetoma; Pseudallescheria | 1985 |